April 18, 2017 / 8:33 PM / 3 months ago

BRIEF-Nivalis Therapeutics and Alpine Immune Sciences Inc agree to combine

1 Min Read

April 18 (Reuters) - Nivalis Therapeutics Inc:

* Nivalis Therapeutics Inc and Alpine Immune Sciences Inc. Agree to combine

* Nivalis therapeutics inc - merger will result in a combined company

* Nivalis Therapeutics Inc - Alpine will merge with a wholly-owned subsidiary of nivalis in an all-stock transaction

* Nivalis Therapeutics-Frazier Healthcare Partners, Alpine Bioventures, Orbimed Advisors to invest additional $17 million into Alpine Immune Sciences

* Nivalis Therapeutics Inc - following merger, current alpine shareholders will own approximately 74 percent of combined company

* Nivalis Therapeutics Inc - transaction has been approved by board of directors of both companies

* Nivalis Therapeutics Inc - upon closing of transaction, name of combined company will become Alpine Immune Sciences Inc Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below